The expression of the melanogenesis pathway genes TYR, TYRP-1, and TYRP-2 and the synthesis of melanin in SH-4 melanoma cells after photodynamic therapy with photolon

Advances in Clinical and Experimental Medicine

Volumn 18, Issue 5, 2009, Pages 449-459

  Kuśmierz, Dariusz ^a   Latocha, Małgorzata ^a   Zielińska, Aleksandra ^a   Nawrocka Musiał, Dominika ^a   Sliupkas Dyrda, Elektra ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

Melanin; Melanoma; Photodynamic therapy (PDT); Photolon

Indexed keywords

FOTOLON; MELANIN; PHOTOLON; PHOTOSENSITIZING AGENT; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; CELL PROLIFERATION; CONTROLLED STUDY; GENE; GENE EXPRESSION; HUMAN; HUMAN CELL; MELANOGENESIS; MELANOMA CELL; PHOTODYNAMIC THERAPY; RADIATION DOSE; SURVIVAL; SYNTHESIS; TYR GENE; TYRP 1 GENE; TYRP 2 GENE;

EID: 72149121798     PISSN: 1230025X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Fabris C, Valduga G, Miotto G: Photosensitization with zinc (II) phthalocyanine as a switch in the decision between apoptosis and necrosis. Cancer Res 2001, 61, 7495-7500. (Pubitemid 32995039)
2. Ruka W, Nowecki ZI, Rutkowski P: Czerniaki skóry u doroslych. Medipage Warszawa 2005.
3. Kumala S, Niemiec P, Widel M, Hancock R, Rzeszowska-Wolny J: Apoptosis and clonogenic survival in three tumour cell lines exposed to gamma rays or chemical genotoxic agents. Cell Mol Biol Lett 2003, 8, 655-665. (Pubitemid 37221403)
4. Latocha M, Pilawa B, Kuśmierz D, Zielińska A, Nawrocka D: Changes in free radicals system on IMR-90 and C-32 cells during photodynamic therapy. Pol J Environ Stud 2006, 15, 4A, 154-156.
5. Córdoba F, Braathen LR, Weissenberger J: 5-aminolaevulinic acid photodynamic therapy in a transgenic mouse model of skin melanoma. Exp Dermatol 2005, 14, 6, 429-437. (Pubitemid 40740394)
6. Saczko J, Kulbacka J, Chwilkowska A: The influence of photodynamic therapy on apoptosis in human melanoma cell line. Folia Histochem Cytobiol 2005, 43, 3, 129-132. (Pubitemid 41136483)
7. Latocha M, Pilawa B, Zdybel M, Wilczok T: Effect of Laser Radiation on Free Radicals in Human Cancer G361 Cells. Acta Physica Pol A 2005, 2, 108, 409-442
8. Nevřelová P, Kolářová H, Bajgar R: Measurement of reactive oxygen species after photodynamic therapy in vitro. Scripta Med 2005, 78, 5, 281-290.
9. Lim DS, Ko SH, Lee WY: Silkworm-pheophorbide a mediated photodynamic therapy against B16F10 pigmented melanoma. J Photochem Photobiol B 2004, 74, 1, 1-6.
10. Urbańska K: Uczulanie pigmentowanych komórek i guzów czerniaków zwierzȩcych na promieniowanie jonizuja̧ce i światło (rozprawa habilitacyjna), Wydawnictwo Uniwersytetu Jagiellonskiego, Kraków 2000.
11. Pasewicz A, Idziak D, Koloczek J: Pair correlation function analysis of 5-(4-hexa-decyloxyphenyl)--10,15,20-tri(4-pyridyl)porphyrin and 5-(4-methoxycarbonylphenyl)-10,15,20-tri(4-pyridyl)porphyrin. J Mol Struct 2008, 875, 1-3, 167-172.
12. Grinholc M, Szramka B, Olender K, Graczyk A: Bactericidal effect of photodynamic therapy against methicillin-resistant Staphylococcus aureus strain with the use of various porphyrin photosensitizers. Acta Biochim PoI 2007, 54, 3, 665-670. (Pubitemid 47584043)
13. Copley L, van der Watt P, Wirtz KW, Parker MI, Leaner VD: Photolon, a chlorin e6 derivative, triggers ROS production and light-dependent cell death via necrosis. IJBCB 2008, 40, 227-235. (Pubitemid 350137875)
14. Ramaswamy B, Manivasager V, Chin WWL, Soo KC, Olivo M: Photodynamic diagnosis of human nosopharyngeal carcinoma xenograft model using the novel Chlorin e6 photosensitizer Fotolon. Int J Oncol 2005, 26, 1501-1506.
15. Istotin YP, Laptsevich TP, Bizyuk SA, Alexandrova EN: Photodynamic efficacy of topical application of chlorine6 - polyvinylpyrrolidone complex in tumor-bearing rats. Exp Oncol 2006, 28, 4, 299-302.
16. Isakau HA, Trukhacheva TV, Zhebentyaev AI, Petrov PT: HPLC study of chlorin e6 and its molecular complex with polyvinylpyrrolidone. Biomed Chromatogr 2007, 21, 318-325.
17. 6 and photolon in the presence of melanin. Optic Spectros 2005, 98, 3, 1562-6911.
18. http://www.genecards.org/cgi-bin/carddisp.pl?gene=TYR.
19. http://www.genecards.org/cgi-bin/carddisp.pl?gene=TYRP1.
20. http://www.genecards.org/cgi-bin/carddisp.pl?gene=TYRP2.
21. Cieszka KA, Hill HZ, Hill GJ, Plonka PM: Growth and pigmentation in genetically related Cloudman S91 melanoma cell lines treated with 3-isobutyl-1-methyl-xanthine and β-melanocyte-stimulating hormone. Exp Dermatol 1995, 4, 4, 192-198.
22. Romanowski T, Markiewicz A, Bednarz N, Bielawski KP: Geny metabolizmu podstawowego jako geny referencyjne w ilościowym oznaczaniu ekspresji genow metoda, real-time PCR. Postepy Hig Med Dosw 2007, 61, 500-510.
23. Trichopoulos N, Damato B: Photodynamic therapy for recurrent hyphema after proton beam radiotherapy of iris melanoma. Graefes Arch Clin Exp Ophthalmol 2007, 245, 10, 1573-1575. (Pubitemid 47423341)
24. Sheleg SV, Zhavrid EA, Khodina TV: Photodynamic therapy with chlorin e6 for skin metastases of melanoma. Photodermatol Photoimmunol Photomed 2004, 20, 21-26. (Pubitemid 38195463)
25. Konopacka M, Rzeszowska-Wolny J: The bystander effect-induced formation of micronucleated cells is inhibited by antioxidants, but the parallel induction of apoptosis and loss of viability are not affected. Mutat Res 2006, 593, 1-2, 32-38. (Pubitemid 43113360)
26. Kumala S, Niemiec P, Widel M, Hancock R, Rzeszowska-Wolny J: Apoptosis and clonogenic survival in three tumour cell lines exposed to gamma rays or chemical genotoxic agents. Cell Mol Biol Lett 2003, 8, 655-665. (Pubitemid 37221403)
27. Córdoba F, Braathen LR, Weissenberger J: 5-aminolaevulinic acid photodynamic therapy in a transgenic mouse model of skin melanoma. Exp Dermatol 2005, 14, 6, 429-437. (Pubitemid 40740394)
28. Monfrecola G, Procaccini EM, D'Onofrio D: Hyperpigmentation induced by topical 5-aminolaevulinic acid plus visible light. J Photochem Photobiol B 2002, 68, 2-3, 147-155. (Pubitemid 35469834)
29. Ma LW: A new method for photodynamic therapy of melanotic melanoma - effects of depigmentation with violet light photodynamic therapy. J Environ Pathol Toxicol Oncol 2007, 26, 3, 167-172.
30. Lim DS, Ko SH, Lee WY: Silkworm-pheophorbide a mediated photodynamic therapy against B16F10 pigmented melanoma. J Photochem Photobiol B 2004, 74, 1, 1-6.